Beating Organs-on-chip dissect human tissues motion states to unlock a new generation of dynamic preclinical models with unprecedented clinical relevance

We operate in different areas

drug-safety-and-efficacy

DRUG DISCOVERY AND SAFETY

BiomimX® provides advanced human in vitro models to detect drug efficacy and adverse effects, representing a more clinically relevant alternative to existing models.

medical-device-assessment

MEDICAL DEVICE ASSESSMENT

In line with the new EU Medical Device Regulation (MDR EU 2017/745), BiomimX® offers advanced preclinical models to test medical device efficacy before undergoing clinical trials.

precision-medicine-biomimx

PRECISION
MEDICINE

Future developments include envisioned precision medicine approaches, where candidate compounds and therapies are screened on disease- and, ultimately, patient-specific models.

Every tissue in the body is subjected to motion

Check out our pipeline to discover how BiomimX® is exploiting motion to develop relevant preclinical models of human organs and diseases

Our Technology

uBeat® innovative technology brings into microscaled setups a unique combination of mechanical stimulation and 3D architecture

Our Products

BiomimX uBeat platform

uBeat® innovative cell culture setups unlock the possibility to create your own 3D dynamic model

Our Services

BiomimX Services

Get relevant data form our qualified uBeat® models through our screening services. BiomimX can be your partner in drug development and personalized medicine applications